Charles River Laboratories International (CRL) Other Non Operating Income: 2009-2025
Historic Other Non Operating Income for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to -$22.6 million.
- Charles River Laboratories International's Other Non Operating Income fell 972.61% to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.4 million, marking a year-over-year decrease of 150.37%. This contributed to the annual value of -$16.5 million for FY2024, which is 117.29% down from last year.
- Latest data reveals that Charles River Laboratories International reported Other Non Operating Income of -$22.6 million as of Q3 2025, which was down 14,787.01% from $154,000 recorded in Q2 2025.
- Over the past 5 years, Charles River Laboratories International's Other Non Operating Income peaked at $115.5 million during Q4 2022, and registered a low of -$39.8 million during Q2 2022.
- Moreover, its 3-year median value for Other Non Operating Income was -$2.7 million (2023), whereas its average is $4.0 million.
- In the last 5 years, Charles River Laboratories International's Other Non Operating Income skyrocketed by 5,476.59% in 2022 and then tumbled by 972.61% in 2025.
- Charles River Laboratories International's Other Non Operating Income (Quarterly) stood at $2.1 million in 2021, then soared by 5,476.59% to $115.5 million in 2022, then dropped by 6.76% to $107.7 million in 2023, then slumped by 121.07% to -$22.7 million in 2024, then crashed by 972.61% to -$22.6 million in 2025.
- Its Other Non Operating Income stands at -$22.6 million for Q3 2025, versus $154,000 for Q2 2025 and -$12.2 million for Q1 2025.